Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00266123
Status:
COMPLETED
Last Update Posted:
2007-12-27
First Post:
2005-12-14
Brief Title:
Study Comparing Two Sirolimus Regimens vs Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Randomized Open-Label Study to Compare the Safety and Efficacy of Two Different Sirolimus Regimens With a Tacrolimus Mycophenolate Mofetil Regimen in De Novo Renal Allograft Recipients
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To demonstrate the superiority of SRL TAC elimination corticosteroids Group I and SRL MMF corticosteroids Group II to TAC MMF corticosteroids Group III with respect to renal allograft function at month 12 post-transplantation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None